{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:03:37Z","timestamp":1781103817941,"version":"3.54.1"},"reference-count":18,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T00:00:00Z","timestamp":1475625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Romidepsin is a novel histone deacetylase inhibitor that is approved for the treatment of cutaneous and peripheral T-cell lymphoma in patients who have had at least one prior therapy. Romidepsin is generally well tolerated, though it comes with a risk of cardiac toxicities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We report a case of electrocardiogram changes in a 64-year-old male with enteropathy-associated T-cell lymphoma, type 2, treated with salvage romidepsin therapy who relapsed after non-myeloablative allogeneic sibling peripheral blood stem cell transplant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Although histone deacetylase inhibitors have been investigated for many years, they have only recently been translated to clinical use as a therapy for malignancies. Furthermore, given their approval for a rare disease, clinicians often have limited experience with the dosing and side effects of histone deacetylase inhibitors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case report and literature review investigates the cardiac side effects of histone deacetylase inhibitors and illustrates the importance of cardiac monitoring prior to and during treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1078155216673229","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T22:19:13Z","timestamp":1475705953000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":25,"title":["Romidepsin-associated cardiac toxicity and ECG changes: A case report and review of the literature"],"prefix":"10.1177","volume":"24","author":[{"given":"Zachary T","family":"Rivers","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Minnesota Medical Center, Minneapolis, MN, USA"},{"name":"Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew R","family":"Oostra","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Transplant, Department of Medicine, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S","family":"Westholder","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Minnesota Medical Center, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M","family":"Vercellotti","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Transplant, Department of Medicine, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,10,5]]},"reference":[{"key":"bibr1-1078155216673229","unstructured":"Istodax (R).\n                      [Package Insert]\n                      Summit, NJ.: Celgene Corp., 2014, http:\/\/www.istodax.com\/wp-content\/uploads\/ISTODAX_PackageInsert.pdf (accessed 27 January 2015)."},{"key":"bibr2-1078155216673229","first-page":"718","volume":"8","author":"Sandor V","year":"2002","journal-title":"Clin Cancer Res"},{"key":"bibr3-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1046\/j.1359-4117.2002.01039.x"},{"key":"bibr4-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-05-1693"},{"key":"bibr5-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-005-6901-7"},{"key":"bibr6-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2689"},{"key":"bibr7-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1715"},{"key":"bibr8-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2095"},{"key":"bibr9-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0318"},{"key":"bibr10-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp270"},{"key":"bibr11-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0109"},{"key":"bibr12-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00861-9"},{"key":"bibr13-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M303113200"},{"key":"bibr14-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19137"},{"key":"bibr15-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00789.2004"},{"key":"bibr16-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.559724"},{"key":"bibr17-1078155216673229","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000147557.75257.ff"},{"key":"bibr18-1078155216673229","first-page":"4916","volume":"62","author":"Furumai R","year":"2002","journal-title":"Cancer Res"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155216673229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155216673229","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155216673229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:16:59Z","timestamp":1777688219000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155216673229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,5]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1177\/1078155216673229"],"URL":"https:\/\/doi.org\/10.1177\/1078155216673229","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,5]]}}}